24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
93.67% |
|
ALZHEIMERS |
6.33% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
82.25% |
|
IL 2 FORCE FIELD BENCHMARKING |
8.36% |
|
ANTIBODY DYNAMICS SIMULATION |
5.22% |
|
ALZHEIMERS |
2.35% |
|
IL 2 DYNAMICS SIMULATIONS |
1.83% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
29.04% |
|
ANTIBODY DYNAMICS SIMULATION |
21.14% |
|
IL 2 FORCE FIELD BENCHMARKING |
13.46% |
|
ANTIBODY AFFINITY MATURATION |
8.29% |
|
IL 2 DYNAMICS SIMULATIONS |
6.74% |
|
ANTIBODY DYNAMICS |
5.21% |
|
IL 2 RECEPTOR DYNAMICS |
4.4% |
|
PARKINSONS |
3.77% |
|
UNSPECIFIED |
1.83% |
|
ALZHEIMERS |
1.56% |
|
STP6 SUGAR TRANSPORT |
1.16% |
|
CANCER |
.87% |
|
ATSTP10 TRANSPORT MECHANISM |
.6% |
|
MEMBRANE TRANSPORT |
.54% |
|
SUCROSE TRANSPORT PLANTS |
.53% |
|
PLANT SUCROSE TRANSPORT |
.5% |
|
ATSTP10 SUCROSE TRANSPORT |
.36% |